Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer
NCT00020748
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
epirubicin hydrochloride
DRUG:
irinotecan hydrochloride
Sponsor
Georgetown University
Collaborators
[object Object]